NasdaqGS:PODDMedical Equipment
Is Insulet Fairly Priced After Its Strong Run and High Earnings Multiple in 2025?
If you are looking at Insulet and wondering whether the recent price makes it a buy, hold, or avoid, you are not alone. This stock often divides opinion among growth focused investors.
After a strong run to around $289.62, the shares are still up 12.8% year to date and 10.0% over the last year, even though the stock has slipped 0.6% in the past week and 12.5% over the past month and remains roughly flat over 3 years while still compounding at 13.2% over 5 years.
Recent attention has centred...